Photo by Štefan Štefančík on Unsplash
Where Rare Disease Patients Are Heard, Believed, and Valued
At Pathways To Trust, we believe that every patient deserves to be heard, believed, and treated with dignity. Our mission is to bring the patient's voice to the center of healthcare, where it belongs.
For many people living with a rare disease, the healthcare journey is long, exhausting, and isolating. Years may pass before they receive an accurate diagnosis, often after seeing multiple specialists and struggling to have their symptoms taken seriously. Patients may also encounter implicit bias—not only related to race or gender, but because their symptoms are difficult to explain or don't fit familiar diagnostic patterns. Some are unfairly labeled as drug-seeking, attention-seeking, or emotionally unstable when they are simply seeking answers and appropriate care. These experiences can profoundly erode trust between patients and healthcare providers.
Beyond the frustration of barriers to care, many patients experience profound isolation. Family, friends, coworkers, and even romantic partners may not understand the daily realities of living with a complex, often invisible condition, creating stigma, misunderstanding, and strained relationships. Rare diseases can also disrupt education, careers, and financial stability. As income declines and medical expenses grow, essential treatments may become unaffordable, limiting access to care and ultimately influencing the course of the disease and quality of life.
Pathways To Trust supports patients with rare diseases in two ways: educating healthcare professionals and empowering patients. Our provider education combines evidence-based clinical training with insights into the emotional, social, educational, and financial realities of living with a rare disease, helping clinicians deliver more compassionate, effective care. CME/CEU-accredited courses are available for physicians, physician assistants, and nurses. For patients, we offer practical education on navigating work, finances, relationships, and daily life with chronic illness.
We also amplify patient voices through Re-Imagining Pain Through Art, a traveling digital exhibition that showcases visual and literary works created by people living with rare diseases and chronic pain who use creativity as a way to cope, heal, and communicate experiences that are often difficult to express in words. The exhibit debuted in Fall 2024 and has since been featured internationally, including a two-month exhibition at The Newark Museum of Art in Spring 2026 and the World Orphan Drug Congress in June 2026. Upcoming exhibitions include Shreveport, Louisiana, during Sickle Cell Awareness Month in September 2026 and the World Orphan Drug Congress in Amsterdam in November 2026. The collection continues to grow, and we welcome submissions from patients around the world whose artwork and writing help others better understand the realities—and resilience—of living with chronic pain.
